Skip to main content

Is B-type natriuretic peptide a risk factor for heart failure in patients treated with bardoxolone methyl?

Journal Article


Download full-text (Open Access)

Abstract


  • Letter to the Editor, comment on article entitled “Risk Factors for Heart Failure in Patients With Type 2 Diabetes Mellitus and Stage 4 Chronic Kidney Disease Treated With Bardoxolone Methyl” by Chin et al in the Journal of Cardiac Failure.

Publication Date


  • 2015

Citation


  • Camer, D. & Huang, X. (2015). Is B-type natriuretic peptide a risk factor for heart failure in patients treated with bardoxolone methyl?. Journal of Cardiac Failure, 21 (3), 258-259.

Scopus Eid


  • 2-s2.0-84923589484

Ro Full-text Url


  • http://ro.uow.edu.au/cgi/viewcontent.cgi?article=1530&context=ihmri

Ro Metadata Url


  • http://ro.uow.edu.au/ihmri/513

Has Global Citation Frequency


Number Of Pages


  • 1

Start Page


  • 258

End Page


  • 259

Volume


  • 21

Issue


  • 3

Place Of Publication


  • United States

Abstract


  • Letter to the Editor, comment on article entitled “Risk Factors for Heart Failure in Patients With Type 2 Diabetes Mellitus and Stage 4 Chronic Kidney Disease Treated With Bardoxolone Methyl” by Chin et al in the Journal of Cardiac Failure.

Publication Date


  • 2015

Citation


  • Camer, D. & Huang, X. (2015). Is B-type natriuretic peptide a risk factor for heart failure in patients treated with bardoxolone methyl?. Journal of Cardiac Failure, 21 (3), 258-259.

Scopus Eid


  • 2-s2.0-84923589484

Ro Full-text Url


  • http://ro.uow.edu.au/cgi/viewcontent.cgi?article=1530&context=ihmri

Ro Metadata Url


  • http://ro.uow.edu.au/ihmri/513

Has Global Citation Frequency


Number Of Pages


  • 1

Start Page


  • 258

End Page


  • 259

Volume


  • 21

Issue


  • 3

Place Of Publication


  • United States